Citation Impact
Citing Papers
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints
2012
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Colorectal cancer statistics, 2023
2023 Standout
De novo design and directed folding of disulfide-bridged peptide heterodimers
2022 StandoutNobel
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Cyclic peptide therapeutics: past, present and future
2017
Accurate de novo design of heterochiral protein–protein interactions
2024 StandoutNobel
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Miniproteins as a Powerful Modality in Drug Development
2020
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Pathogenesis of Staphylococcus aureus Abscesses
2015
Bowel Disorders
2016 Standout
Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis
2013
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Diaminodiacid Bridges to Improve Folding and Tune the Bioactivity of Disulfide‐Rich Peptides
2015
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Comparison of Virulence in Community‐Associated Methicillin‐ResistantStaphylococcus aureusPulsotypes USA300 and USA400 in a Rat Model of Pneumonia
2008
Macrophages in immunoregulation and therapeutics
2023 Standout
Host Defense and Pathogenesis in Staphylococcus aureus Infections
2009
Two Randomized Trials of Linaclotide for Chronic Constipation
2011
Neutrophils in innate host defense against Staphylococcus aureus infections
2011
The Research Agenda of the National Institute of Allergy and Infectious Diseases for Antimicrobial Resistance
2008
The Role of Macrophages in Staphylococcus aureus Infection
2021
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
2012
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
2015
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate
2013
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Irritable bowel syndrome
2016 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry
2020 StandoutNobel
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial
2015
Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?
2011
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
2010
Designing hydrogels for controlled drug delivery
2016 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
In vitro-engineered non-antibody protein therapeutics
2017
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
2014
Fluids and gastrointestinal function
2011
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
De novo design of buttressed loops for sculpting protein functions
2024 StandoutNobel
Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus
2013
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Staphylococcus aureus determinants for nasal colonization
2012
Trends in peptide drug discovery
2021
The human skin microbiome
2018 Standout
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
2012
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation
2007
Irritable Bowel Syndrome
2015 Standout
Orally Absorbed Cyclic Peptides
2017
Emerging Frontiers in Drug Delivery
2016
Resolution of Staphylococcus aureus Biofilm Infection Using Vaccination and Antibiotic Treatment
2011
The Current State of Peptide Drug Discovery: Back to the Future?
2017
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Cell Wall-Anchored Surface Proteins of Staphylococcus aureus: Many Proteins, Multiple Functions
2015
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
2017 Standout
A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
2012 Standout
A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus
2010 Standout
Antibodies toStaphylococcus aureuscapsular polysaccharides 5 and 8 perform similarlyin vitrobut are functionally distinctin vivo
2016
Transcription of Inflammatory Genes in the Lung after Infection with Community-Associated Methicillin-Resistant Staphylococcus aureus : a Role for Panton-Valentine Leukocidin?
2009
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers
2021
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
2019
Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureus
2007
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
NorB, an Efflux Pump in Staphylococcus aureus Strain MW2, Contributes to Bacterial Fitness in Abscesses
2008
Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host
2009
MetaUniDec: High-Throughput Deconvolution of Native Mass Spectra
2018
Works of Robert Solinga being referenced
Molecular characterization of the capsule locus from non‐typeable Staphylococcus aureus
2005
CD4 + T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections
2006
Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model
2006
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
2010
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract
2010
Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase
2017
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
2012